Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
[powerpress]
Please feel free to offer comments and raise questions in our
discussion forums.
Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.
Since your doctor didn't seem too worried...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.